Base de dados : HANSEN
Pesquisa : MYCOBACTERIUM BOVIS/PATOGEN [Descritor de assunto]
Referências encontradas : 7 [refinar]
Mostrando: 1 .. 7   no formato [Detalhado]

página 1 de 1

  1 / 7 HANSEN  
              next record last record
seleciona
para imprimir
Texto Completo-pt
Id:25929
Autor:Campos, Nelson Souza.
Título:O BCG na profilaxia da lepra. À luz das conclusões dos congressos internacionais e reuniões de cúpula da OMS.
Fonte:Rev. bras. Leprol;30(1/2):55-64, jan.-jun. 1962. .
Descritores:Mycobacterium bovis/imunol
Mycobacterium bovis/fisiol
Mycobacterium bovis/patogen
Hanseníase/epidemiol
Hanseníase/imunol
Hanseníase/prev
Hanseníase/fisiopatol
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/brasleprol/1962/PDF/v30n1-2/v30n1-2a04.pdf - pt.
Localização:BR191.1


  2 / 7 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Texto Completo-pt
Id:25871
Autor:Hadler, W. A; Ziti, L. M.
Título:Efeito da vacinação pelo BCG sôbre a evolução da lepra murina; observação em ratos inoculados, por via peritoneal, com pequena dose de M. lepraemurium / Effect of BCG vaccination on the evolution of murine leprosy; observation in mice inoculated by peritoneal route, with a small dose of M. lepraemurium
Fonte:Rev. bras. Leprol;22(2):124-134, jun. 1954. ^bilus, ^bgraf.
Resumo:The peritoneal inoculation of M. lepraemurium in the rat produces generalized lesions and a disease which shows uniforms evolution. The evolutive speed depends on the weight of inoculated bacilli. The incoculations of nearly o.03 mg of M. lepraemurium provokes only histological lesions, which progress very slowly. This slow evolution permits the observation of the influence of previous mycobacterial vaccination upon the progress and the influence of the citology of the lesions, allowing the study of the acquired resistance. Fifty young rats were divided in 4 lots: 1) 13 rats vaccinated with 25 mg of BCG by oral route; 2) 12 rats vaccinated with 5 mg of BCG, by oral route; 3) 12 rats vaccinated with 5 mg of BCG, by intramuscular route; 4) 13 non vaccinated rats (controls). All animals were inoculated 90 days after vaccination with a suspension containing approximately 0.03 mg of M. lepraemurium (by peritoneal route) and observed 450 days. The gain of weight and the histological picture observed in vaccinated and control animals are identicals; the disease shows the same evolution. The BCG vaccination does not suscitate, in the rat, acquired resistance against M. lepraemurium demonstrable by histological methods. The lesions in the vaccinated and control groups reach the same intensity in the lymph nodes, liver and apleen, and show the same slow evolution. In the animals of both groups the lesions remain almost stationary (during the all observed time), or grow slowly and progressively, or more rarely undergo involution (without complete disappearing). The histological method also shows that macrophages of the normal rat have no ability to destroy the M. lepraemurium, M. leprae and M. tuberculosis; the BCG vaccination does not induce at the macrophages the aptitude to lyse these acid-fast bacilli. On the other hand, the macrophages of normal guinea pigs have the ability to lyse these mycobacteria; the BCG vaccination provokes in the guinea pigs this physiologic...(AU)^ien.
Descritores:Mycobacterium lepraemurium/genet
Mycobacterium lepraemurium/fisiol
Mycobacterium lepraemurium/patogen
Mycobacterium bovis/patogen
Hanseníase/imunol
Hanseníase/fisiopatol
Limites:Animais
Meio Eletrônico:http://hansen.bvs.ilsl.br/textoc/revistas/brasleprol/1954/PDF/v22n2/v22n2a02.pdf - pt.
Localização:BR191.1


  3 / 7 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:25083
Autor:Anon
Título:The US-Japan Cooperative Medical Science Program Tuberculosis and leprosy Panel's 36th Annual Research Conference, New Orleans, Louisiana, USA, 15-17 July 2001
..-
Fonte:s.l; s.n; 2002. 23 p. .
Conferência:Apresentado em: Leprosy Panel annual research conference, 36, New Orleans, 15-17 july 2001.
Descritores:MYCOBACTERIUM/clas
MYCOBACTERIUM/cresc
MYCOBACTERIUM/imunol
MYCOBACTERIUM/patogen
MICOBACTERIAS ATIPICAS/cresc
MICOBACTERIAS ATIPICAS/imunol
MICOBACTERIAS ATIPICAS/isol
MICOBACTERIAS ATIPICAS/metab
MICOBACTERIAS ATIPICAS/fisiol
MICOBACTERIAS ATIPICAS/patogen
MYCOBACTERIUM AVIUM/cresc
MYCOBACTERIUM AVIUM/imunol
MYCOBACTERIUM AVIUM/patogen
MYCOBACTERIUM BOVIS/imunol
MYCOBACTERIUM BOVIS/patogen
MYCOBACTERIUM LEPRAE/imunol
MYCOBACTERIUM LEPRAE/patogen
MYCOBACTERIUM TUBERCULOSIS/cresc
MYCOBACTERIUM TUBERCULOSIS/imunol
MYCOBACTERIUM TUBERCULOSIS/isol
MYCOBACTERIUM TUBERCULOSIS/patogen
ANTITUBERCULOSOS/admin
ANTITUBERCULOSOS/ef adv
ANTITUBERCULOSOS/uso terap
COOPERACAO INTERNACIONAL
 COOPERACAO TECNICA
 VACINA BCG/admin
Limites:HUMANO
ANIMAL
Localização:BR191.1; 09068/s


  4 / 7 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:16421
Autor:Casanova, Jean-Laurent; Abel, Laurent
Título:Genetic dissection of immunity to mycobacteria: the human model
..-
Fonte:s.l; s.n; 2002. 40 p. ilus, tab.
Descritores:MICROBIOLOGIA AMBIENTAL
IMUNIDADE
SINDROMES DE DEFICIENCIA IMUNOLOGICA
SINDROMES DE DEFICIENCIA IMUNOLOGICA
SINDROMES DE DEFICIENCIA IMUNOLOGICA
INTERFERON TIPO II
INTERLEUCINA-12
MODELOS IMUNOLOGICOS
MYCOBACTERIUM
MYCOBACTERIUM
MICOBACTERIOSE
MICOBACTERIOSE
MICOBACTERIOSE
MYCOBACTERIUM BOVIS
MYCOBACTERIUM BOVIS
VIRULENCIA
Localização:BR191.1; 08717/s


  5 / 7 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:15908
Autor:Casanova, Jean-Laurent; Abel, Laurent
Título:Genetic dissecation of immunity to mycobacteria: the human model
..-
Fonte:s.l; s.n; 2002. 50 p. ilus, tab.
Descritores:MICROBIOLOGIA AMBIENTAL
MYCOBACTERIUM
MYCOBACTERIUM
IMUNIDADE
INTERFERON TIPO II
MYCOBACTERIUM BOVIS
MYCOBACTERIUM BOVIS
Localização:BR191.1; 08548/s


  6 / 7 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:15803
Autor:Gordon, S; Andrew, P. W
Título:Mycobacterial virulence factors
..-
Fonte:s.l; s.n; 1996. 12 p. tab.
Descritores:HANSENIASE
HANSENIASE
HANSENIASE
MYCOBACTERIUM BOVIS
MYCOBACTERIUM BOVIS
MYCOBACTERIUM BOVIS
MYCOBACTERIUM BOVIS
MYCOBACTERIUM TUBERCULOSIS
MYCOBACTERIUM TUBERCULOSIS
MYCOBACTERIUM TUBERCULOSIS
MYCOBACTERIUM TUBERCULOSIS
CAPSULAS BACTERIANAS
CAPSULAS BACTERIANAS
GENÉTICA BIOQUIMICA
PEROXIDO DE HIDROGENIO
LISOSSOMOS
LISOSSOMOS
MICOBACTERIOSE
MICOBACTERIOSE
MICOBACTERIOSE
OXIRREDUÇAO
FAGOCITOS
FAGOCITOS
FAGOCITOS
FAGOSSOMOS
FAGOSSOMOS
TUBERCULOSE
TUBERCULOSE
TUBERCULOSE
TUBERCULOSE AVIARIA
TUBERCULOSE AVIARIA
TUBERCULOSE AVIARIA
TUBERCULOSE BOVINA
TUBERCULOSE BOVINA
TUBERCULOSE BOVINA
VIRULENCIA
Localização:BR191.1; 08520/s


  7 / 7 HANSEN  
              first record previous record
seleciona
para imprimir
Id:15553
Autor:Gordon, S; Andrew, P. W
Título:Mycobacterial virulence factors
..-
Fonte:s.l; s.n; 1996. 13 p. tab.
Descritores:HANSENIASE
HANSENIASE
HANSENIASE
COMPLEXO MYCOBACTERIUM AVIUM
COMPLEXO MYCOBACTERIUM AVIUM
COMPLEXO MYCOBACTERIUM AVIUM
COMPLEXO MYCOBACTERIUM AVIUM
MYCOBACTERIUM BOVIS
MYCOBACTERIUM BOVIS
MYCOBACTERIUM BOVIS
MYCOBACTERIUM BOVIS
MYCOBACTERIUM TUBERCULOSIS
MYCOBACTERIUM TUBERCULOSIS
MYCOBACTERIUM TUBERCULOSIS
MYCOBACTERIUM TUBERCULOSIS
CAPSULAS BACTERIANAS
CAPSULAS BACTERIANAS
GENÉTICA BIOQUIMICA
PEROXIDO DE HIDROGENIO
OXIRREDUÇAO
FAGOCITOS
FAGOCITOS
FAGOCITOS
FAGOSSOMOS
FAGOSSOMOS
TUBERCULOSE
TUBERCULOSE
TUBERCULOSE
TUBERCULOSE BOVINA
TUBERCULOSE BOVINA
TUBERCULOSE BOVINA
VIRULENCIA
Localização:BR191.1; 08395/s



página 1 de 1
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information